The short version
- Women from minority ethnic groups in England are up to 33% less likely to receive a breast cancer diagnosis through routine screening programs compared to their white counterparts.
- The study found that these same demographics are significantly more likely to be diagnosed through urgent referrals or emergency presentations, suggesting systemic barriers to early detection.
- Researchers attribute poorer survival rates among marginalized groups to inequalities in access to screening and delays in initiating treatment, highlighting the need for targeted policy interventions.
A comprehensive analysis of breast cancer diagnoses in England has uncovered persistent inequalities affecting women from minority ethnic backgrounds. The research, conducted by academics at the University of Surrey and supported by the charity Breast Cancer Now, examined data from over 86,000 adults diagnosed between 2009 and 2019. The findings indicate that individuals from Black, Asian, and mixed heritage communities are up to one-third less likely to be identified through routine screening programs than those from white backgrounds.
Instead of early detection via standard checks, women from these marginalized groups are disproportionately diagnosed through more critical pathways. The data shows they are up to 31% more likely to receive a diagnosis following an urgent suspected cancer referral and up to 37% more likely to present in an emergency setting. This shift toward later-stage identification is concerning because early detection is widely recognized as a key factor in improving survival rates and expanding treatment options for breast cancer patients.
The study also highlighted disparities linked to socioeconomic status, noting that individuals from deprived backgrounds face similar challenges in accessing routine screening. Beyond ethnicity and income, the research identified specific barriers for people with learning disabilities. These patients experienced an 18% longer time to diagnosis and waited 10% longer for treatment initiation compared to those without learning disabilities. These delays contribute to poorer overall cancer outcomes for this vulnerable population.
Manveet Basra, associate director of public health at Breast Cancer Now, emphasized that these statistics reflect systemic issues rather than isolated incidents. She noted that marginalized groups encounter inequalities at every stage of their breast cancer journey, which tragically impacts their survival prospects. Understanding who is less likely to be screened and who faces delays in diagnosis allows policymakers and healthcare providers to identify specific barriers and work toward eliminating them.
Dr. Rob Kerrison, the lead investigator from the University of Surrey, pointed out that while it has long been known that some groups have poorer breast cancer survival rates, the underlying reasons were not fully understood. The new findings suggest that unequal access to screening and timely treatment are significant contributing factors. He argued that improving outcomes requires ensuring that everyone can access screening services and receive prompt care, regardless of their background or personal circumstances.
This research builds on existing evidence regarding healthcare disparities in England. Previous studies have shown that ethnic minorities often require more visits to general practitioners before receiving a cancer diagnosis. While one in five people across England needs three or more GP interactions for a diagnosis, this figure rises to one in three for those from ethnic minority backgrounds. These repeated interactions suggest that symptoms may be overlooked or dismissed initially, leading to delayed referrals and later-stage diagnoses.
The implications of these findings extend beyond individual patient care to broader public health strategy. Breast cancer is the most common cancer worldwide among women, accounting for approximately one in four cancer cases and remaining a leading cause of death for women under 50. Identifying high-risk groups early can facilitate additional screening measures or preventive treatments. However, current data suggests that young Black women, who are more likely to develop aggressive tumors, remain significantly underrepresented in clinical research, further complicating efforts to tailor effective care.
In response to these disparities, Breast Cancer Now is funding world-class research aimed at actively identifying and addressing inequities. The charity is working with policymakers to improve equal access to screening and ensure that information campaigns and support services reflect the diverse needs of all patients. By focusing on removing barriers to early detection and treatment, stakeholders hope to close the survival gap and provide more equitable care for women across all demographic groups in England.
Sources behind this briefing
Go to the original reporting
- The Guardian World↗Ethnic minorities in England less likely to get breast cancer diagnosis from routine screening
